Micropep raises €8.75 million to deliver cost-effective alternatives to conventional crop protection

Micropep, an ag-biotech company developing biological micropeptide-based solutions for agriculture, has announced the completion of a €8.75 million Series A1 financing round.

Fall Line Capital led the Series A1, less than a year after the Series A, in addition to existing investors, Supernova Invest, Sofinnova Partners, FMC Ventures and IRDI/SORIDEC.

Eric O’Brien, co-founder and Managing Partner of Fall Line Capital said: ‘Micropep has developed a truly novel technology platform in ag-biotech that promises to bring farmers highly effective new and environmentally safe crop protection solutions. We have been impressed by the broad potential of Micropep’s micropeptide discovery platform and by the vision of its leadership team. We are eager to provide our expertise to support the company and its expansion in the US.

Read more on Scientific Computing